A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Clinical trial NCT02951988 · COMPLETED
Trial details
- NCT number
- NCT02951988
- Sponsor
- Naurex, Inc, an affiliate of Allergan plc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-13
- Primary completion
- 2019-02-22
- Enrollment
- 1304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.